PDXliver: a database of liver cancer patient derived xenograft mouse models

PDXliver: a database of liver cancer patient derived xenograft mouse models

Abstract Background Liver cancer is the second leading cause of cancer-related deaths and characterized by heterogeneity and drug resistance. Patient-derived xenograft (PDX) models have been widely used in cancer research because they reproduce the characteristics of original tumors. However, the cu...

Full description

Bibliographic Details
Main Authors:	Sheng He, Bo Hu, Chao Li, Ping Lin, Wei-Guo Tang, Yun-Fan Sun, Fang-You-Min Feng, Wei Guo, Jia Li, Yang Xu, Qian-Lan Yao, Xin Zhang, Shuang-Jian Qiu, Jian Zhou, Jia Fan, Yi-Xue Li, Hong Li, Xin-Rong Yang
Format:	Article
Language:	English
Published:	BMC 2018-05-01
Series:	BMC Cancer
Subjects:	Liver cancer PDX model Drug response Database
Online Access:	http://link.springer.com/article/10.1186/s12885-018-4459-6

Similar Items

A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal adenocarcinoma
by: Zhenyang Liu, et al.
Published: (2020-06-01)

Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma
by: Lorena Landuzzi, et al.
Published: (2021-02-01)

Current status and perspectives of patient-derived xenograft models in cancer research
by: Yunxin Lai, et al.
Published: (2017-05-01)

Patient-Derived Xenograft Models of Breast Cancer and Their Application
by: Takahiko Murayama, et al.
Published: (2019-06-01)

Factors that influence response classifications in chemotherapy treated patient-derived xenografts (PDX)
by: Joan E. Malcolm, et al.
Published: (2019-03-01)

Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response
by: Feifei Zhang, et al.
Published: (2018-09-01)

Murine Endogenous Retroviruses Are Detectable in Patient-Derived Xenografts but Not in Patient-Individual Cell Lines of Human Colorectal Cancer
by: Stephanie Bock, et al.
Published: (2018-04-01)

Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts
by: Chiara Agnoletto, et al.
Published: (2018-10-01)

Guided chemotherapy based on patient-derived mini-xenograft models improves survival of gallbladder carcinoma patients
by: Ming Zhan, et al.
Published: (2018-07-01)

Enhancing efficacy of gemcitabine in pancreatic patient-derived xenograft mouse models
by: Andriana Inkoom, et al.
Published: (2020-12-01)

Assessment of a mouse xenograft model of primary colorectal cancer with special reference to perfluorooctane sulfonate
by: Jeffrey H. Wimsatt, et al.
Published: (2018-11-01)

Establishment of a Jaw Fibrosarcoma Patient-Derived Xenograft and Evaluation of the Tumor Suppression Efficacy of Plumbagin Against Jaw Fibrosarcoma
by: Yuqi Xin, et al.
Published: (2020-08-01)

Generation of glioblastoma patient-derived organoids and mouse brain orthotopic xenografts for drug screening
by: Christian Moya Gamboa, et al.
Published: (2021-03-01)

Patient-Derived Orthotopic Xenograft Models of Pediatric Brain Tumors: In a Mature Phase or Still in Its Infancy?
by: Eva Hermans, et al.
Published: (2020-01-01)

Establishing a clinically relevant orthotopic xenograft model of patient-derived glioblastoma in zebrafish
by: Ai, X., et al.
Published: (2022)

Patient-derived xenograft models in musculoskeletal malignancies
by: Wan Lu, et al.
Published: (2018-04-01)

Patient-derived non-small cell lung cancer xenograft mirrors complex tumor heterogeneity
by: Xuanming Chen, et al.
Published: (2021-02-01)

Establishment and evaluation of four different types of patient-derived xenograft models
by: Xiaoqian Ji, et al.
Published: (2017-12-01)

Increased Tumor Growth Rate and Mesenchymal Properties of NSCLC-Patient-Derived Xenograft Models during Serial Transplantation
by: José Miguel Pardo-Sánchez, et al.
Published: (2021-06-01)

Characterization and validation of potential therapeutic targets based on the molecular signature of patient-derived xenografts in gastric cancer
by: Zuhua Chen, et al.
Published: (2018-02-01)

Development of clinically relevant in vivo metastasis models using human bone discs and breast cancer patient-derived xenografts
by: Diane Lefley, et al.
Published: (2019-11-01)

Establishment of patient‐derived xenograft model of peritoneal mucinous carcinomatosis with signet ring cells and in vivo study on the efficacy and toxicity of intraperitoneal injection of 5‐fluorouracil
by: Yu‐Lin Lin, et al.
Published: (2020-02-01)

Patient-Derived Xenograft Models in Cervical Cancer: A Systematic Review
by: Tomohito Tanaka, et al.
Published: (2021-08-01)

Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts
by: A. Capasso, et al.
Published: (2019-02-01)

Patient Derived Xenografts Expand Human Primary Pancreatic Tumor Tissue Availability for ex vivo Irreversible Electroporation Testing
by: Rebecca M. Brock, et al.
Published: (2020-05-01)

Neoantigens retention in patient derived xenograft models mediates autologous T cells activation in ovarian cancer
by: Muzamil Yaqub Want, et al.
Published: (2019-06-01)

DCE-MRI of patient-derived xenograft models of uterine cervix carcinoma: associations with parameters of the tumor microenvironment
by: Anette Hauge, et al.
Published: (2017-11-01)

Comparison between NOD/SCID mice and BALB/c mice for patient-derived tumor xenografts model of non-small-cell lung cancer
by: Wu J, et al.
Published: (2018-12-01)

A Comparative Quantitative LC-MS/MS Profiling Analysis of Human Pancreatic Adenocarcinoma, Adjacent-Normal Tissue, and Patient-Derived Tumour Xenografts
by: Orla Coleman, et al.
Published: (2018-11-01)

The design, analysis and application of mouse clinical trials in oncology drug development
by: Sheng Guo, et al.
Published: (2019-07-01)

Large-scale single-cell transcriptomics of osteosarcoma reveals extensive and different heterogeneity in primary tumors versus murine xenograft model
by: Halvorsen, Stefan
Published: (2016)

Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity
by: Federico La Manna, et al.
Published: (2020-06-01)

Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft Models
by: Alice C. O’Farrell, et al.
Published: (2020-10-01)

Comparative Assessment of Antitumor Effects and Autophagy Induction as a Resistance Mechanism by Cytotoxics and EZH2 Inhibition in INI1-Negative Epithelioid Sarcoma Patient-Derived Xenograft
by: Silvia Stacchiotti, et al.
Published: (2019-07-01)

Distinct cachexia profiles in response to human pancreatic tumours in mouse limb and respiratory muscle
by: Rachel L. Nosacka, et al.
Published: (2020-06-01)

Corrigendum: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity
by: Federico La Manna, et al.
Published: (2021-02-01)

A systematic review of the validity of patient derived xenograft (PDX) models: the implications for translational research and personalised medicine
by: Anne T. Collins, et al.
Published: (2018-11-01)

Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer
by: Xingxiang Pu, et al.
Published: (2018-11-01)

Patient-Derived Xenograft Models in Cancer Research
by: Wytske M. van Weerden
Published: (2021-02-01)

Novel monoclonal antibodies against Pdx1 reveal feedback regulation of Pdx1 protein levels
by: T. Galbo, et al.
Published: (2010-04-01)